1 / 2

India API Industry Market

Indian pharmaceutical industry is gaining momentum owing to significant contributions from generic brands, a wide range of API manufacturers, and robust demand for API post-COVID-9 pandemic.

farazp70
Télécharger la présentation

India API Industry Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. India API Industry Market Growth, Trends Analysis & Forecast to 2026 Indian pharmaceutical industry is gaining momentum owing to significant contributions from generic brands, a wide range of API manufacturers, and robust demand for API post- COVID-9 pandemic. India is the largest provider of generic drugs around the globe. It supplies over 60.0% of the global demand for vaccines, 40.0% of the generic demand in the US, and 25.0% of all medicines in the UK, as per India Brand Equity Foundation (IBEF). APIs are now mostly imported from other emerging and developed markets in the country. Get Free Sample Copy @https://marketinsight.in/request-sample/india-api-market- industry-size Indian API industry comprises a network of over 10,500 manufacturers and 3,000 pharma companies and holds the highest share in the generic drug market. Indian API industry is rapidly changing and there are various vital factors influencing these changes. India has more than 262 API plants, which is the largest number of US-FDA compliant pharma plants outside the US. India has around 1400 WHO-GMP approved pharma plants, 253 European Directorate of Quality Medicines (EDQM) approved plants with modern state of the art Technology which makes it attractive destination for pharmaceutical market players. A Full Report of India API Industry is Available at:https://marketinsight.in/industry- reports/india-api-market-industry-size India is gaining huge importance in API outsourcing across the globe owing to cohesive regulatory policies, favorable government initiatives, and growing investment from foreign market players. Globally, India is one of the top suppliers of bulk drugs and formulations. It has the highest number of US FDA approved plants (665) outside the US as well as 44.0% of the global abbreviated new drug applications (ANDA). Moreover, the API contract manufacturers are expanding their production facilities to meet the clients’ demands. These contract manufacturers include Lonza Group Ltd., Natco Pharma Ltd., and Olon S.p.A. For instance, in April 2019, Olon S.p.A., an API CDMO declared the acquisition of a manufacturing facility in Mahad, India. For More Customized Data, Request for Report Customization @ https://marketinsight.in/report-customization/india-api-market-industry-size About Market Insight Marketinsight.in, a sub-division of Orion Market Research (OMR), is a determined market research firm that simply aims at providing services such as consulting, customize research, field research and a growth strategy plan to the Indian enterprises. It provides a complete

  2. suite of customized services focused on to bringing process efficiency and market effectiveness in its services. Media Contact: Company Name: Market Insight Contact Person: Mr. Anurag Tiwari Email: info@marketinsight.in Contact no: +91 780-304-0404

More Related